Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Gavreto (pralsetinib)
.
Show all posts
Showing posts with label
Gavreto (pralsetinib)
.
Show all posts
Tuesday, January 19, 2021
FDA Approves Gavreto (pralsetinib) for the Treatment of Adults With Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer
›
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced the U.S. Food and Drug Administration (FDA) approval of Gav...
›
Home
View web version
